on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Key Conferences in September 2025
Jaguar Health, Inc. announced that its founder and CEO, Lisa Conte, will speak at two upcoming virtual conferences. The first is the Emerging Growth Conference on September 25, 2025, from 2:55 to 3:05 PM Eastern Time. The second is the Lytham Partners Fall 2025 Conference on September 30, 2025, at 3:30 PM Eastern Time. Both presentations aim to provide updates on the company's near-term catalysts.
Jaguar Health focuses on developing plant-based prescription medicines for gastrointestinal distress. Their subsidiary, Napo Pharmaceuticals, produces crofelemer, an FDA-approved drug for noninfectious diarrhea in HIV/AIDS patients. Meanwhile, Napo Therapeutics aims to expand crofelemer access in Europe and for orphan diseases.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news